Safety of Crossing Donor-specific Antibodies in Lung Transplantation.

Transplantation(2022)

Cited 1|Views17
No score
Abstract
Crossing DSA at time of lung transplant was not associated with an increased risk of death or CLAD in our cohort, but patients developed severe PGD and antibody-mediated rejection more frequently. However, these risks are likely manageable when balanced against the benefits of expanded access for sensitized candidates.
More
Translated text
Key words
transplantation,lung,donor-specific
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined